Sarepta Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
149.40
|
|
Average Rating
|
4.35
|
|
# Strong Buys
|
11
|
|
# Buys
|
5
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.43
|
-2.94
|
-1.51
|
-105.59%
|
|
2022-06-30
|
-1.18
|
-2.65
|
-1.47
|
-124.58%
|
|
2022-03-31
|
-1.27
|
-1.20
|
0.07
|
5.51%
|
|
2021-12-31
|
-1.13
|
-1.42
|
-0.29
|
-25.66%
|
|
2021-09-30
|
-1.89
|
-0.60
|
1.29
|
68.25%
|
|
2021-06-30
|
-1.28
|
-1.02
|
0.26
|
20.31%
|
|
2021-03-31
|
-1.74
|
-2.10
|
-0.36
|
-20.69%
|
|
2020-12-31
|
-1.78
|
-2.40
|
-0.62
|
-34.83%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.79
|
|
2021-12-31
|
-5.14
|
|
2020-12-31
|
-7.06
|
|
2019-12-31
|
-9.67
|
|
2018-12-31
|
-5.42
|
|
2017-12-31
|
-0.80
|
|
2016-12-31
|
-4.71
|
|
2015-12-31
|
-5.19
|
|
2014-12-31
|
-3.39
|
|
2013-12-31
|
-3.39
|
|
2012-12-31
|
-3.09
|
|
2011-12-31
|
-0.06
|
|
2010-12-31
|
-1.80
|
|
2009-12-31
|
-1.74
|
|
2008-12-31
|
-2.04
|
|
2007-12-31
|
-3.24
|
|
2006-12-31
|
-3.60
|
|
2005-12-31
|
-2.28
|
|
2004-12-31
|
-4.14
|
|
2003-12-31
|
-3.66
|
|
2002-12-31
|
-6.28
|
|
2001-12-31
|
-7.11
|
|
2000-12-31
|
-18.45
|